 This will be a quasi-experimental study design with a goal of 60 patients about to undergo surgical or invasive procedures requiring an IV catheter insertion in the pre op department at West Kendall Baptist Hospital (WKBH).
 Patient who receive, as standard of practice, 1% licocaine prior to IV insertion Will be compared to those that did not.
 The study sample will consist of 60 patients aged 18 years and older  To be included in the study participants have to have IV accesses established, and the ability to express their pain level.
 The data collection tool of the study will consist of a questionnaire that include patient demographic information and questions about pain perception and anxiety experienced with IV insertion.
 Eligible patients will be introduce to the study with a cover letter, and ask to voluntarily participate in the study.
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The use of Procalcitonin as a sepsis marker in a community hospital
This study explores and describes the use of PCT in a community hospital setting. We investigated its diagnostic accuracy in predicting sepsis and its usefulness as an early marker compared to lactic acid. It also explored the impact on patient care pre and post implementation of procalcitonin in regards to direct costs and length of stay for sepsis patients.
Two methods were utilized in this study:
• Method 1: Two comparative groups were analyzed in an exploratory descriptive casecontrol study with secondary analysis of retrospective data over a 19 month period after PCT implementation. • Method 2: A control group consisting of emergency department patients were analyzed in a retrospective quasi-experimental study from a 19 month period before PCT implementation.
Procalcitonin (PCT) is a biomarker that aids in the diagnosis and monitoring of sepsis. Its levels begin to rise as soon as 3-6 hours after an infection is detected by the immune system. It has shown to be an early and highly specific marker in response to sepsis and severe systemic bacterial infections.
In our community hospital, a majority of admitted patients are first treated in the emergency department. As discussed, PCT is a better tool than the traditional lactic acid and this has resulted in increased acceptance and utilization in the emergency room and hospital units. Typically the length of stay has the greatest influence on cost, so further review is needed to improve it and pinpoint savings. Additionally, we need to investigate if time to treat or treatment plan also attributes to cost savings.
There was a positive correlation between lactic acid and PCT values. In predicting sepsis cases with positive blood cultures, PCT (>0.1 ng/mL) had a sensitivity of 89.7% while lactic acid's sensitivity (>2mmol/L) was 64.9%. Also, there was a significant decrease in cost of hospitalization, where the median cost pre-PCT was $10,271 and post-PCT was $6,981. Neither, the length of stay (hospital or ICU) nor the time to the first antibiotic administration demonstrated a difference pre-and post-PCT implementation.
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We confirmed that PCT had a higher sensitivity in our hospital than lactic acid, offering a higher predictive usefulness in determining patients with positive blood cultures. From the results, it was suggested to lower the lactic acid cut off to 1.4mmol/L to improve sensitivity however, it decreased specificity and positive predictive value. The cost savings observed could be associated with a variable outside length of stay, or our measurement was not precise enough to show a decrease in length of stay. 
